{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:05Z","timestamp":1790842025724,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010360","name":"University of Oxford Saint Cross College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRN0248501"],"award-info":[{"award-number":["MRN0248501"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014748","name":"Clarendon Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.omtn.2022.10.010","type":"journal-article","created":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T09:38:10Z","timestamp":1666517890000},"page":"379-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin\/utrophin double-knockout mouse model of DMD"],"prefix":"10.1016","volume":"30","author":[{"given":"Britt","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Stenler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Chwalenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Svrzikapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.L.","family":"Coenen-Stass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3313-7631","authenticated-orcid":false,"given":"Thomas C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.10.010_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2022.10.010_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.expneurol.2005.11.021","article-title":"Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice","volume":"198","author":"Messina","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtn.2022.10.010_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","article-title":"mdx mice show progressive weakness and muscle deterioration with age","volume":"129","author":"Pastoret","year":"1995","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.omtn.2022.10.010_bib4","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1242\/jcs.03000","article-title":"Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration","volume":"119","author":"Yokota","year":"2006","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtn.2022.10.010_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-021-01862-w","article-title":"The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review","volume":"16","author":"Szabo","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2022.10.010_bib6","first-page":"83","article-title":"Autopsy analyses of the muscular dystrophies","volume":"40","author":"Moriuchi","year":"1993","journal-title":"Tokushima J. Exp. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.amjcard.2016.01.031","article-title":"Relation of cardiac dysfunction to rhythm abnormalities in patients with Duchenne or becker muscular dystrophies","volume":"117","author":"Chiang","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.omtn.2022.10.010_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nmd.2010.09.006","article-title":"Duchenne muscular dystrophy: survival by cardio-respiratory interventions","volume":"21","author":"Ishikawa","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2022.10.010_bib9","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/brain\/awr291","article-title":"Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials","volume":"134","author":"Anthony","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2022.10.010_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.omtn.2022.10.010_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.10.010_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI116989","article-title":"Immunohistochemical analysis of dystrophin-associated proteins in Becker\/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin","volume":"93","author":"Matsumura","year":"1994","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2022.10.010_bib13","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases--a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2022.10.010_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2022.10.010_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2022.10.010_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2022.10.010_bib18","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2022.10.010_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","article-title":"Regulation of homologous recombination in eukaryotes","volume":"44","author":"Heyer","year":"2010","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib26","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.10.010_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib29","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib31","doi-asserted-by":"crossref","first-page":"e124297","DOI":"10.1172\/jci.insight.124297","article-title":"AAV CRISPR editing rescues cardiac and muscle function for 18\u00a0months in dystrophic mice","volume":"3","author":"Hakim","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2022.10.010_bib32","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2022.10.010_bib33","doi-asserted-by":"crossref","first-page":"eaay6812","DOI":"10.1126\/sciadv.aay6812","article-title":"Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2022.10.010_bib34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/15476286.2021.1874161","article-title":"Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing","volume":"18","author":"Hanson","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2022.10.010_bib35","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","article-title":"CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox","volume":"9","author":"Sen\u00eds","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2022.10.010_bib36","article-title":"Gene transfer in skeletal and cardiac muscle using recombinant adeno-associated virus","volume":"14","author":"Gruntman","year":"2013","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.omtn.2022.10.010_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-61779-370-7_5","article-title":"Gene therapy in skeletal muscle mediated by adeno-associated virus vectors","volume":"807","author":"Qiao","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2022.10.010_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib40","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nmeth.2681","article-title":"Orthogonal Cas9 proteins for RNA-guided gene regulation and editing","volume":"10","author":"Esvelt","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2022.10.010_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.10.010_bib42","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.omtn.2022.10.010_bib43","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1093\/hmg\/ddw237","article-title":"Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation","volume":"25","author":"Coenen-Stass","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib44","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1038\/srep08986","article-title":"Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice","volume":"5","author":"Betts","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.10.010_bib45","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1074\/mcp.RA120.002345","article-title":"Mutation-independent proteomic signatures of pathological progression in murine models of Duchenne muscular dystrophy","volume":"19","author":"van Westering","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.omtn.2022.10.010_bib46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2022.10.010_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2022.10.010_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/mt.2009.248","article-title":"Prevention of dystrophic pathology in severely affected dystrophin\/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping","volume":"18","author":"Goyenvalle","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib49","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/hmg\/dds082","article-title":"Rescue of severely affected dystrophin\/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping","volume":"21","author":"Goyenvalle","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib51","doi-asserted-by":"crossref","first-page":"eaan0713","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jcsm.12506","article-title":"Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology","volume":"11","author":"van Westering","year":"2020","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omtn.2022.10.010_bib53","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2022.10.010_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-020-01106-1","article-title":"The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy","volume":"9","author":"Scaglioni","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtn.2022.10.010_bib55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In\u00a0vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice","volume":"121","author":"El Refaey","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2022.10.010_bib56","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/gt.2014.53","article-title":"Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice","volume":"21","author":"Wu","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib57","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/mtna.2014.1","article-title":"The dynamics of compound, transcript, and protein effects after treatment with 2OMePS antisense oligonucleotides in mdx mice","volume":"3","author":"Verhaart","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.10.010_bib58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajpath.2012.04.006","article-title":"Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino","volume":"181","author":"Wu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2022.10.010_bib59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9\u2013mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2022.10.010_bib60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.nmd.2007.07.005","article-title":"Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human","volume":"17","author":"Neri","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2022.10.010_bib61","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","article-title":"How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse","volume":"24","author":"Godfrey","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib62","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/hmg\/4.8.1245","article-title":"Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy","volume":"4","author":"Wells","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2022.10.010_bib63","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41587-020-0642-9","article-title":"High-dose AAV gene therapy deaths","volume":"38","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2022.10.010_bib65","author":"Vinluan"},{"key":"10.1016\/j.omtn.2022.10.010_bib66","series-title":"Novartis Reports Zolgensma Caused Two Deaths from Liver Failure","author":"Reuters","year":"2022"},{"key":"10.1016\/j.omtn.2022.10.010_bib67","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in\u00a0vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib68","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/sj.gt.3302133","article-title":"Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib69","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.ymthe.2020.10.005","article-title":"Application of CRISPR-Cas9-mediated genome editing for the treatment of myotonic dystrophy type 1","volume":"28","author":"Marsh","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0092-8674(89)90597-7","article-title":"Nuclear domains in muscle cells","volume":"59","author":"Hall","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2022.10.010_bib71","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2022.10.010_bib72","doi-asserted-by":"crossref","first-page":"e31937","DOI":"10.1371\/journal.pone.0031937","article-title":"The effects of low levels of dystrophin on mouse muscle function and pathology","volume":"7","author":"van Putten","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.10.010_bib73","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.omtn.2022.08.033","article-title":"Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties","volume":"29","author":"Chwalenia","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.10.010_bib74","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"van Putten","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.omtn.2022.10.010_bib75","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM198805263182104","article-title":"Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne\u2019s or Becker\u2019s muscular dystrophy","volume":"318","author":"Hoffman","year":"1988","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib76","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.ymthe.2018.09.003","article-title":"Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR\/Cas9","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.10.010_bib77","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.10.010_bib78","doi-asserted-by":"crossref","first-page":"e1602814","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2022.10.010_bib79","doi-asserted-by":"crossref","first-page":"14038","DOI":"10.1038\/mtm.2014.38","article-title":"Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells","volume":"1","author":"Arnett","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2022.10.010_bib80","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.10.010_bib81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","article-title":"Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the USA population","volume":"10","author":"Simhadri","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2022.10.010_bib82","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of Streptococcus pyogenes Cas9-reactive T\u00a0cells within the adult human population","volume":"25","author":"Wagner","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2022.10.010_bib83","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1371\/journal.pone.0003647","article-title":"A one pot, one step, precision cloning method with high throughput capability","volume":"3","author":"Engler","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.10.010_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1480-9222-16-5","article-title":"Detection and quantification of extracellular microRNAs in murine biofluids","volume":"16","author":"Roberts","year":"2014","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.omtn.2022.10.010_bib85","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR edits from Sanger trace data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2022.10.010_bib86","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtn.2022.10.010_bib87","doi-asserted-by":"crossref","first-page":"e89237","DOI":"10.1371\/journal.pone.0089237","article-title":"Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum","volume":"9","author":"Roberts","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.10.010_bib88","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.10.010_bib89","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: pairwise alignment for nucleotide sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2022.10.010_bib90","doi-asserted-by":"crossref","first-page":"e0163962","DOI":"10.1371\/journal.pone.0163962","article-title":"SeqKit: a cross-platform and ultrafast toolkit for FASTA\/Q file manipulation","volume":"11","author":"Shen","year":"2016","journal-title":"PLoS One"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:32:10Z","timestamp":1761874330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":89,"alternative-id":["S2162253122002761"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.10.010","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.25.477678","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin\/utrophin double-knockout mouse model of DMD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}